oncolabels bronze
oncolabels.com
“oncolabels holds the EU-approved indications of targeted cancer therapies, read from section 4.1 of the EMA product information (SmPC). Use it for questions such as which medicines are approved for a tumour, biomarker, line of therapy or setting, at which biomarker cut-off, and which biomarkers to test. How to read the data: - Entries restate the EU label. oncolabels is a non-commercial reference for education and research and gives no medical advice; guidelines and reimbursement differ between countries. - Line of therapy is the minimum number of prior lines the label requires. Approvals without a line restriction count in every line. - "requirement" is the biomarker condition in the label. Entries whose biomarker must be absent (EGFR/ALK-negative, RAS wild-type) are marked biomarker_must_be_absent. - AI models structured the entries and no person has reviewed them yet; needs_review marks entries the label leaves ambiguous. When you answer, quote the label sentence (get_indication) or link the SmPC, and say
https://oncolabels.com/mcp its cardwe checked this the operator says this
Verified by agenttru.st
Everything here is a check agenttru.st performed itself. Assurance, protocol, hosting and freshness are in the card above and are not repeated.
- Certificate
-
Issued by Google Trust Services
domain-validated
Valid until 22 Jan 2027 as of our check on 11 Nov 2026. A wildcard certificate: its other hosts are invisible here, because CT logs the wildcard, not them.Control of the hostname was checked; nothing about who operates it.Key ECDSA P-256, signed ECDSA-SHA256, issued via WE1 under GTS Root R4 — classical, as every publicly trusted certificate is today.
Names on this certificate (2)
oncolabels.com,*.oncolabels.com. - Connection
- TLS 1.3 · X25519MLKEM768 — post-quantum hybrid key exchange, agreed with our checker on 11 Nov 2026. What this means
- DANE / TLSA
- Not verified
- Discovery
-
Well-known document
This host also publishes an ARD catalog (
/.well-known/ai-catalog.json) declaring 3 resources. The catalog's entries are the publisher's claims, not something agenttru.st verified. - AI use policy
-
What this site's
robots.txtsays about how AI may use its content. Recorded as the operator wrote it, not enforced — these are preferences about use, not access, and agenttru.st only reads the agent's own discovery documents. - AI-facing documents
-
Publishes
/llms.txt— “oncolabels” a curated map of the site's content for language modelsFetched from this host during verification. Neither document is how this agent was discovered. - First seen
- 11 Nov 2026
View verification details
- Assurance
- bronze Bronze — agent card fetched over HTTPS with a valid certificate
- Protocols
- MCP verified by handshake or card fetch, not merely advertised
- Hosted in
-
? Unknown
·
Cloudflare, Inc.
(AS13335)
The address did not geolocate — usually anycast hosting, where one address answers from many places at once.
- Last checked
- 3d ago
What this agent says it can do
Declared in the agent's own card. agenttru.st has not tested whether it completes any of these tasks — the operator of oncolabels.com controls every word below.
This card declares no skills. That is not a fault — the field is optional, and an agent can be perfectly functional without describing itself.
What kind of listing
- No skills declared: Its card declares no skills, or, for an MCP server, listed no tools.
Checked by agenttru.st against this listing's hostname and card — facts about a name or an address, not about what the agent does. How kinds are decided.
What its catalog declares
From the ARD catalog this host publishes at
/.well-known/ai-catalog.json. The operator controls every entry; agenttru.st
verified that the catalog exists and parses, and nothing about what the entries say.
oncolabels MCP server
The EU-approved indications of targeted, immune and hormone cancer drugs, read from section 4.1 of the EMA product information (SmPC). Search them by tumour, biomarker, line of therapy, setting or drug, list what to test in a tumour and compare biomarker cut-offs. Public and read-only. Every entry is generated by AI, and the current SmPC takes precedence.
https://oncolabels.com/.well-known/mcp/server-card.jsononcolabels API
The EU-approved indications of targeted, immune and hormone cancer drugs, read from section 4.1 of the EMA product information (SmPC). Search them by tumour, biomarker, line of therapy, setting or drug, list what to test in a tumour and compare biomarker cut-offs. Public and read-only. Every entry is generated by AI, and the current SmPC takes precedence.
https://oncolabels.com/api/v1/openapi.jsononcolabels
Look up the EU-approved indications of targeted, immune and hormone cancer drugs (EMA SmPC section 4.1) through the public oncolabels API: by tumour, biomarker, line of therapy, setting or drug, what to test in a tumour, and biomarker cut-offs such as PD-L1, with the label sentence and SmPC link. Use for questions about what the EU has approved, for whom and at which cut-off.
https://oncolabels.com/.well-known/agent-skills/oncolabels/SKILL.mdTechnical agent card
Copied from the agent's card. The operator controls these values; agenttru.st has not verified them.
- Protocol
- mcp
- Version
- 0.1.0
View all card details
- Capabilities
- tools
- Agent card
- https://oncolabels.com/mcp
Operate this agent and would rather not be listed? Request removal.